FDA - Edgentiq

FDA Committee to Deliberate on Risks and Regulation of AI Mental Health Chatbots

Peer AI Secures $12.1 Million to Expedite FDA Drug Approvals with AI-Powered Regulatory Platform

Affinia Therapeutics Secures $40 Million Series C to Advance Gene Therapies for Heart and Brain Conditions

FDA Seeks Public Input on Real-World Performance of AI-Powered Medical Devices

Navigating Generative AI in Healthcare: A Look at Performance Evaluation Strategies

Recently Added

Ketryx Secures $39 Million Series B to Advance AI-Powered Compliance in Life Sciences

Generative AI Reshapes Medical Imaging and Patient Care Amid Evolving Regulatory Landscape

The AI Regulator is Here: Why the FDA’s ‘Elsa’ Demands a New Playbook for Policy and Ethics Professionals

FDA’s AI Tool ‘Elsa’ Poised to Transform Pharmaceutical Regulatory Submissions

The Black Box Is Closed: Why the FDA’s GenAI Stance Is a Red Alert for Life Sciences

FDA’s Embrace of Generative AI Prompts Call for Transparency and Validation in Pharmaceutical and Biotech Sectors

FDA’s New AI Tool, Elsa, Plagued by Hallucinations and Inaccuracies, Employees Report

FDA Unveils ‘Elsa’ AI Tool, Promising Accelerated Regulatory Approvals

Zimmer Biomet Acquires Monogram Technologies to Advance AI-Powered Orthopedic Robotics

FDA Unveils ‘Elsa’ AI Tool to Accelerate Food Safety Responses and Streamline Recalls

Achieve Life Sciences and Omnicom Pioneer AI-Driven Strategy for Cytisinicline Drug Launch

- Advertisement -

FDA Committee to Deliberate on Risks and Regulation of AI Mental Health Chatbots

November 5, 2025

Peer AI Secures $12.1 Million to Expedite FDA Drug Approvals with AI-Powered Regulatory Platform

October 18, 2025

Affinia Therapeutics Secures $40 Million Series C to Advance Gene Therapies for Heart and Brain Conditions

October 18, 2025

Financial Sector Fortifies Against Surging AI-Powered Scams

Deloitte’s 2025 Outlook: Navigating Escalating AI Challenges in Human Capital

Salesforce Study Reveals Data Quality is Pivotal for Employee Trust in AI Adoption

Top Executives Sidestep Company AI Guidelines, Fueling Shadow AI Risks

Intel’s Evolving IP Strategy: A Calculated Shift Towards Core AI Innovation

Generative AI Prompts Increased Workforce Surveillance in Indian IT Sector

Financial Sector Fortifies Against Surging AI-Powered Scams

Deloitte’s 2025 Outlook: Navigating Escalating AI Challenges in Human Capital

Salesforce Study Reveals Data Quality is Pivotal for Employee Trust in AI Adoption

Top Executives Sidestep Company AI Guidelines, Fueling Shadow AI Risks

Intel’s Evolving IP Strategy: A Calculated Shift Towards Core AI Innovation

Generative AI Prompts Increased Workforce Surveillance in Indian IT Sector

Peer AI Secures $12.1 Million to Expedite FDA Drug Approvals with AI-Powered Regulatory Platform

Affinia Therapeutics Secures $40 Million Series C to Advance Gene Therapies for Heart and Brain Conditions

FDA Seeks Public Input on Real-World Performance of AI-Powered Medical Devices

Navigating Generative AI in Healthcare: A Look at Performance Evaluation Strategies

Recently Added

Ketryx Secures $39 Million Series B to Advance AI-Powered Compliance in Life Sciences

Generative AI Reshapes Medical Imaging and Patient Care Amid Evolving Regulatory Landscape

The AI Regulator is Here: Why the FDA’s ‘Elsa’ Demands a New Playbook for Policy and Ethics Professionals

FDA’s AI Tool ‘Elsa’ Poised to Transform Pharmaceutical Regulatory Submissions

The Black Box Is Closed: Why the FDA’s GenAI Stance Is a Red Alert for Life Sciences

FDA’s Embrace of Generative AI Prompts Call for Transparency and Validation in Pharmaceutical and Biotech Sectors

FDA’s New AI Tool, Elsa, Plagued by Hallucinations and Inaccuracies, Employees Report

FDA Unveils ‘Elsa’ AI Tool, Promising Accelerated Regulatory Approvals

Zimmer Biomet Acquires Monogram Technologies to Advance AI-Powered Orthopedic Robotics

FDA Unveils ‘Elsa’ AI Tool to Accelerate Food Safety Responses and Streamline Recalls

Achieve Life Sciences and Omnicom Pioneer AI-Driven Strategy for Cytisinicline Drug Launch

Gen AI News and Updates

FDA Committee to Deliberate on Risks and Regulation of AI Mental Health Chatbots

Peer AI Secures $12.1 Million to Expedite FDA Drug Approvals with AI-Powered Regulatory Platform

Affinia Therapeutics Secures $40 Million Series C to Advance Gene Therapies for Heart and Brain Conditions

Subscribe to get the latest news and updates